Seda Banu Akinci

Chair for Critical Care, Division of Critical Care
Director, Multidisciplinary Critical Care Medicine Fellowship Education Program
Department of Anesthesiology and Reanimation
Hacettepe University Faculty of Medicine, Ankara, Turkey

Dr. Seda Banu Akıncı earned her M.D. from the Hacettepe University, Ankara, Turkey. She trained in Anesthesiology in the same university after which, she completed a fellowship in Critical Care Medicine in Johns Hopkins University, Baltimore, USA. She has served on the Medical Faculty at Hacettepe University since 2001.
She has spent many years for the education of medical students, residents and intensive care fellows. She believes the standardization of anesthesia and ICU education across different programs both within and between countries is very important and cooperation between different countries can help to improve this standardization. During her management of different ICU’s (postoperative, mixed medical and surgical, and COVID Unit, lately), she has spent years to improve communication, well-being and team work between different professionals including physicians, nurses, pharmacists, dietitians, and other health care personnel. As the director of the largest multidisciplinary critical care medicine fellowship education program of Turkey, she has worked with fellows from many different backgrounds (Anesthesiology, Surgery, Chest diseases, Infectious diseases, Internal medicine, Neurology) and observers from many different countries. She organized many courses regarding ultrasonography, mechanical ventilation, airway management, sedation and analgesia in the ICU.
She currently is a member of the Intensive & Critical Care Medicine (ICCM) Committee of World Federation of Societies of Anesthesiologists (WFSA) and serves on the editorial boards of many national and international scientific journals. She has actively worked for the scientific preparation of national /international symposiums and congresses. She is especially interested in experimental research in sepsis. She is also actively engaged in clinical trials on critically ill patients with COVID-19.